Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Niki BioSolutions, Inc. NIKI

Full chart Compare
Set alert

Price alert · NIKI

All alert types
1.75 USD +0.17 (+10.76%)

At closeNov 10, 2026, 6:08 AM EST

1.65 -0.10 -5.71%

Pre-market · Nov 10, 6:08 AM ET

1.65 Day range 1.75
1.42 52-week range 17.20
YTD
-83.49%
1 year
-87.50%

Financial health

Altman Z-Score

-5.85 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -5.6×
FY 2017: -169×FY 2018: -28.6×FY 2019: -24.8×FY 2020: 12.2×FY 2021: -2.1×FY 2022: -2.0×FY 2023: -4.0×FY 2024: -3.6×FY 2025: -5.6×
FY 2017 5y median -3.6× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 1105×FY 2019: 859×FY 2020: 84.4×FY 2021: 34.1×FY 2022: 15.1×FY 2023: 25.7×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 15.1× FY 2025
P/B 0.3×
FY 2017: 14.3×FY 2018: 12.8×FY 2019: 28.1×FY 2020: 1.8×FY 2021: 2.2×FY 2022: 1.2×FY 2023: 0.4×FY 2024: 0.7×FY 2025: 0.3×
FY 2017 5y median 0.7× FY 2025
P/FCF -4.2×
FY 2017: -48.9×FY 2018: -26.3×FY 2019: -31.7×FY 2020: -4.8×FY 2021: -3.6×FY 2022: -1.6×FY 2023: -1.4×FY 2024: -12.8×FY 2025: -4.2×
FY 2017 5y median -3.6× FY 2025
EV/EBITDA -4.3×
FY 2017: -166×FY 2018: -42.2×FY 2019: -30.5×FY 2020: 11.8×FY 2021: -1.7×FY 2022: -2.5×FY 2023: -1.3×FY 2024: -4.8×FY 2025: -4.3×
FY 2017 5y median -2.5× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 1100×FY 2019: 862×FY 2020: 84.2×FY 2021: 28.9×FY 2022: 19.0×FY 2023: 28.6×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 19.0× FY 2025
FCF Yield -23.6%
FY 2017: -2.0%FY 2018: -3.8%FY 2019: -3.2%FY 2020: -20.9%FY 2021: -28.1%FY 2022: -63.7%FY 2023: -69.8%FY 2024: -7.8%FY 2025: -23.6%
FY 2017 5y median -28.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 17.1%FY 2019: -48.4%FY 2020: -11.4%FY 2021: 5.3%FY 2022: 6.2%FY 2023: 2.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 2.4% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: -2693.4%FY 2019: -3400.4%FY 2020: -2182.6%FY 2021: -1245.6%FY 2022: -1351.0%FY 2023: -2457.5%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -1245.6% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: -3868.0%FY 2019: -3491.8%FY 2020: 775.3%FY 2021: -1624.4%FY 2022: -756.2%FY 2023: -654.9%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -654.9% FY 2025
ROE -5.9%
FY 2017: -8.4%FY 2018: -44.8%FY 2019: -114.2%FY 2020: 16.9%FY 2021: -106.1%FY 2022: -62.4%FY 2023: -11.4%FY 2024: -20.2%FY 2025: -5.9%
FY 2017 5y median -20.2% FY 2025
ROIC -10.4%
FY 2017: -18.4%FY 2018: -24.0%FY 2019: -85.3%FY 2020: -48.0%FY 2021: -107.1%FY 2022: -119.2%FY 2023: -56.8%FY 2024: -25.1%FY 2025: -10.4%
FY 2017 5y median -56.8% FY 2025
ROA -7.3%
FY 2017: -8.1%FY 2018: -32.9%FY 2019: -78.0%FY 2020: 16.0%FY 2021: -114.3%FY 2022: -47.0%FY 2023: -13.7%FY 2024: -26.5%FY 2025: -7.3%
FY 2017 5y median -26.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 39.6%FY 2020: 70.3%FY 2021: 69.2%FY 2022: -16.0%FY 2023: -66.7%FY 2024: -100.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 52.1%
FY 2017: 0.0%FY 2018: -81.4%FY 2019: -76.2%FY 2020: -9.3%FY 2021: 3.5%FY 2022: 8.8%FY 2023: 39.5%FY 2024: 64.2%FY 2025: 52.1%
FY 2017 FY 2025
EPS (diluted) 75.6%
FY 2017: 0.0%FY 2018: -524.7%FY 2019: -20.5%FY 2020: 131.3%FY 2021: -457.5%FY 2022: 61.5%FY 2023: 77.5%FY 2024: -25.8%FY 2025: 75.6%
FY 2017 FY 2025
Free Cash Flow -54.4%
FY 2017: 0.0%FY 2018: -82.1%FY 2019: 10.0%FY 2020: -11.1%FY 2021: 8.1%FY 2022: 15.4%FY 2023: 38.2%FY 2024: 84.6%FY 2025: -54.4%
FY 2017 FY 2025

Financial Health

Current Ratio 0.8×
FY 2017: 15.2×FY 2018: 2.4×FY 2019: 3.0×FY 2020: 8.7×FY 2021: 2.9×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 0.2×FY 2025: 0.8×
FY 2017 5y median 0.8× FY 2025
Quick Ratio 0.8×
FY 2017: 14.1×FY 2018: 2.4×FY 2019: 3.0×FY 2020: 8.7×FY 2021: 2.9×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 0.2×FY 2025: 0.8×
FY 2017 5y median 0.8× FY 2025
Debt / Equity 0.1×
FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2017: 6.3×FY 2018: 0.2×FY 2019: -0.1×FY 2020: -0.0×FY 2021: 0.3×FY 2022: -0.5×FY 2023: -0.1×FY 2024: -0.7×FY 2025: 0.0×
FY 2017 5y median -0.1× FY 2025
Interest Coverage -19.0×
FY 2017: 0.0×FY 2018: -2.3×FY 2019: -4.9×FY 2020: -81.7×FY 2021: -205×FY 2022: 0.0×FY 2023: -87.5×FY 2024: -25.8×FY 2025: -19.0×
FY 2017 5y median -25.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 1.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 10.7%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31